Clinical Research Directory
Browse clinical research sites, groups, and studies.
Antibiotic Prophylaxis for Bladder Botox
Sponsor: University of Alberta
Summary
Injection of Botox into the bladder is a common treatment for overactive bladder. Postoperative bladder infection is one of the more frequently reported complications of this procedure. Prophylactic antibiotics given at the time of bladder Botox for the reduction of postoperative bladder infection have not been well studied. The main goal of our study is to determine if prophylactic antibiotics at the time of bladder Botox injection for the treatment of overactive bladder in women reduces postoperative bladder infection. The investigators are proposing a study which will randomize participants into two groups - one receiving Ciprofloxacin and the other receiving placebo pills for three days following the procedure. The primary outcome evaluated will be the difference in postoperative bladder infection between the two groups. The investigators will also investigate differences in reported side effects between the two groups possibly related to antibiotic use. Follow-up will be over six weeks following the procedure.
Official title: Prophylactic Antibiotics During Treatment of Idiopathic Overactive Bladder With Intradetrusor onabotulinumtoxinA for the Reduction of Postoperative UTI: a Randomized Blinded Placebo-controlled Trial
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
202
Start Date
2021-06-28
Completion Date
2026-06-30
Last Updated
2025-09-03
Healthy Volunteers
No
Interventions
Ciprofloxacin
Fluoroquinolone antibiotic.
Placebo Pill
Placebo Pill
Locations (1)
Urogynecology Clinic - Royal Alexandra Hospital
Edmonton, Alberta, Canada